Skip to nav Skip to content

Clinical Trial Search

360 Clinical Trials Found

Clinical Trial 23082

Disease Site: Melanoma, skin
PI: Karapetyan, Lilit

Clinical Trial 23208

Disease Site: Soft Tissue
PI: Komrokji, Rami

Clinical Trial 23226

Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia
PI: Mishra, Asmita

Clinical Trial 23652

A Phase 1, multicenter, open-label study of UB-VV111 in combination with rapamycin in relapsed/refractory (R/R) CD19+ hematologic malignancies
Disease Site: Hodgkin's Lymphoma, Lymphoid Leukemia, Non-Hodgkin's Lymphoma
PI: Shah, Bijal

Clinical Trial 23335

Disease Site: Multiple Myeloma
PI: Nguyen, Nina

Clinical Trial 23369

Disease Site: Other
PI: Grogan, Patrick

Clinical Trial 23454

Disease Site: Soft Tissue
PI: Gaballa, Sameh

Clinical Trial 23556

A Phase 1 Study of MLN7243 (TAK-243) for Either Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome/Chronic Myelomonocytic Leukemia Refractory to Hypomethylating Agents
Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS)
PI: Lancet, Jeffrey

Clinical Trial 23641

Disease Site: Unknown Sites
PI: Pidala, Joseph

Clinical Trial 21192

A Phase 2 Study of the Combination Dostarlimab with Niraparib In Patients with Penile Carcinoma Who Have Progressed Following Chemotherapy
Disease Site: Other Male Genital
PI: Chadha, Juskaran

Clinical Trial 20937

A Multicenter, Phase II Trial of Pembrolizumab and Sunitinib In Refractory Advanced Thymic Carcinoma
Disease Site: Other Respiratory and Intrathoracic Organs
PI: Tanvetyanon, Tawee

Clinical Trial 22540

A Phase 1, open-label, multicenter, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of VVD-130037, a Kelch-like ECH-associated protein 1 (KEAP1) activator, in participants with advanced solid tumors
Disease Site: Lung
PI: Chiappori, Alberto